[
    {
        "question_number": 1,
        "qid": 579,
        "text": "Which drugs target ITGA11, a gene involved in integrin cell surface interactions and linked to ovarian disease?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "Dasatinib",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01254"
            },
            {
                "entity_name": "Cyclosporine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00091"
            },
            {
                "entity_name": "Valproic acid",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Magnesium cation",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01378"
            }
        ],
        "resource": [
            {
                "entity_name": "ITGA11",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UKX5/entry"
            },
            {
                "entity_name": "Integrin cell surface interactions",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-216083"
            }
        ]
    },
    {
        "question_number": 2,
        "qid": 582,
        "text": "Which drugs target TFDP2, a gene involved in the Oncogene-Induced Senescence pathway and associated with ovarian disorders?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "ATP",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00171"
            },
            {
                "entity_name": "Dihydrogenphosphate",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB02831"
            }
        ],
        "resource": [
            {
                "entity_name": "TFDP2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q14188/entry"
            },
            {
                "entity_name": "Oncogene Induced Senescence",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-2559585"
            }
        ]
    },
    {
        "question_number": 3,
        "qid": 658,
        "text": "Which drugs target DYNLRB1, a gene involved in the intraflagellar transport pathway and associated with ovarian disorders?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "Valproic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00313"
            },
            {
                "entity_name": "Acetaminophen",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00316"
            }
        ],
        "resource": [
            {
                "entity_name": "DYNLRB1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9NP97/entry"
            },
            {
                "entity_name": "Intraflagellar transport",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-5620924"
            }
        ]
    },
    {
        "question_number": 4,
        "qid": 684,
        "text": "What functional regions are present in the protein KPNA7, which is involved in the ISG15 antiviral mechanism pathway and linked to ovarian disease?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "Importin beta binding domain",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Atypical Arm repeat",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Armadillo/beta-catenin-like repeat",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "KPNA7",
                "entity_link": "https://www.uniprot.org/uniprotkb/A9QM74/entry"
            },
            {
                "entity_name": "ISG15 antiviral mechanism",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-1169408"
            }
        ]
    },
    {
        "question_number": 5,
        "qid": 697,
        "text": "Which metabolites are linked to B4GALT3, a gene involved in the N-glycan antennae elongation pathway and associated with ovarian disorders?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "N-Acetyllactosamine",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Uridine diphosphategalactose",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "N-Acetyl-D-glucosamine",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Uridine 5'-diphosphate",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Manganese",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "B4GALT3",
                "entity_link": "https://www.uniprot.org/uniprotkb/O60512/entry"
            },
            {
                "entity_name": "N-Glycan antennae elongation",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-975577"
            }
        ]
    },
    {
        "question_number": 6,
        "qid": 785,
        "text": "Which proteins interact with B4GALT2, a gene involved in the N-glycan antennae elongation pathway and linked to ovarian disorders?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "ST3GAL3",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/H0YEP7/entry"
            },
            {
                "entity_name": "LALBA",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P00709/entry"
            },
            {
                "entity_name": "OGN",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P20774/entry"
            },
            {
                "entity_name": "LUM",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P51884/entry"
            },
            {
                "entity_name": "KERA",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/O60938/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "B4GALT2",
                "entity_link": "https://www.uniprot.org/uniprotkb/O60909/entry"
            },
            {
                "entity_name": "N-Glycan antennae elongation",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-975577"
            }
        ]
    },
    {
        "question_number": 7,
        "qid": 831,
        "text": "Which proteins are involved in the De Novo Triacylglycerol Biosynthesis pathway for TG(22:1(13Z)/18:3(9Z,12Z,15Z)/22:1(13Z)) and are linked to kidney failure?",
        "category": "urinary system disease:kidney failure",
        "llm_ranking": [
            {
                "entity_name": "LPIN1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q14693/entry"
            },
            {
                "entity_name": "DGAT1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O75907/entry"
            },
            {
                "entity_name": "GPD1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P21695/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "De Novo Triacylglycerol Biosynthesis TG(22:1(13Z)/18:3(9Z,12Z,15Z)/22:1(13Z))",
                "entity_link": "http://smpdb.ca/view/SMP0023693"
            }
        ]
    },
    {
        "question_number": 8,
        "qid": 851,
        "text": "Which proteins are associated with endometriosis and function as subunits of the ITGA4-ITGB1-CD81 complex?",
        "category": "reproductive system disease:endometriosis",
        "llm_ranking": [
            {
                "entity_name": "CD81",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P60033/entry"
            },
            {
                "entity_name": "ITGB1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P05556/entry"
            },
            {
                "entity_name": "ITGA4",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P13612/entry"
            }
        ],
        "resource": []
    },
    {
        "question_number": 9,
        "qid": 881,
        "text": "Which proteins are linked to vulvovaginitis and interact with RNF185?",
        "category": "reproductive system disease:vulvovaginitis",
        "llm_ranking": [
            {
                "entity_name": "SPATA5",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8NB90/entry"
            },
            {
                "entity_name": "ACOT8",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O14734/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "RNF185",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q96GF1/entry"
            }
        ]
    },
    {
        "question_number": 10,
        "qid": 886,
        "text": "Which proteins interact with SLC25A27 and are linked to acute cystitis?",
        "category": "urinary system disease:cystitis",
        "llm_ranking": [
            {
                "entity_name": "LEP",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P41159/entry"
            },
            {
                "entity_name": "REL",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q04864/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "SLC25A27",
                "entity_link": "https://www.uniprot.org/uniprotkb/O95847/entry"
            }
        ]
    },
    {
        "question_number": 11,
        "qid": 894,
        "text": "Which proteins interact with JUND and are linked to glomerulosclerosis?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "HMOX1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P09601/entry"
            },
            {
                "entity_name": "BATF3",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9NR55/entry"
            },
            {
                "entity_name": "MAPK14",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q16539/entry"
            },
            {
                "entity_name": "MAPK1",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P28482/entry"
            },
            {
                "entity_name": "CCND1",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P24385/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "JUND",
                "entity_link": "https://www.uniprot.org/uniprotkb/P17535/entry"
            }
        ]
    },
    {
        "question_number": 12,
        "qid": 921,
        "text": "Which proteins are subunits of the Ubiquitin E3 ligase complex (SMURF2, SMAD3, SnoN) that is TGF-beta-dependent and linked to reproductive system diseases?",
        "category": "reproductive system disease:None",
        "llm_ranking": [
            {
                "entity_name": "SKIL",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P12757/entry"
            },
            {
                "entity_name": "SMURF2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9HAU4/entry"
            },
            {
                "entity_name": "SMAD3",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P84022/entry"
            }
        ],
        "resource": []
    },
    {
        "question_number": 13,
        "qid": 923,
        "text": "Which proteins are linked to cystic kidney disease and are known to interact with SMAP2?",
        "category": "urinary system disease:cystic kidney disease",
        "llm_ranking": [
            {
                "entity_name": "ARL13B",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q3SXY8/entry"
            },
            {
                "entity_name": "AXL",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P30530/entry"
            },
            {
                "entity_name": "SMAD9",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/O15198/entry"
            },
            {
                "entity_name": "TMCO2",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q7Z6W1/entry"
            },
            {
                "entity_name": "CLTC",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q00610/entry"
            },
            {
                "entity_name": "SLC2A4",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P14672/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "SMAP2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8WU79/entry"
            }
        ]
    },
    {
        "question_number": 14,
        "qid": 925,
        "text": "Which proteins are subunits of the NFAT-JUN-FOS DNA-protein complex and are linked to obstructive nephropathy?",
        "category": "urinary system disease:obstructive nephropathy",
        "llm_ranking": [
            {
                "entity_name": "FOS",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01100/entry"
            },
            {
                "entity_name": "JUN",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P05412/entry"
            }
        ],
        "resource": []
    },
    {
        "question_number": 15,
        "qid": 949,
        "text": "Which drugs cause hemoglobinuria as a side effect and interact with gabapentin enacarbil?",
        "category": "Abnormality of the genitourinary system:Abnormality of the urinary system physiology",
        "llm_ranking": [
            {
                "entity_name": "Deferiprone",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB08826"
            },
            {
                "entity_name": "Quinidine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00908"
            },
            {
                "entity_name": "Quinine",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00468"
            },
            {
                "entity_name": "Doxepin",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01142"
            },
            {
                "entity_name": "Sertraline",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB01104"
            }
        ],
        "resource": [
            {
                "entity_name": "Gabapentin enacarbil",
                "entity_link": "https://go.drugbank.com/drugs/DB08872"
            }
        ]
    },
    {
        "question_number": 16,
        "qid": 976,
        "text": "Which proteins are involved in the phosphatidylethanolamine biosynthesis pathway (PE(22:4/18:3)) and are linked to prostate disease?",
        "category": "reproductive system disease:prostate disease",
        "llm_ranking": [
            {
                "entity_name": "PTDSS1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P48651/entry"
            },
            {
                "entity_name": "CHKA",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P35790/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Phosphatidylethanolamine Biosynthesis PE(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))",
                "entity_link": "http://smpdb.ca/view/SMP0015732"
            }
        ]
    },
    {
        "question_number": 17,
        "qid": 983,
        "text": "Which proteins are linked to urethral stricture and are involved in the FGFR1 signaling pathway in disease?",
        "category": "urinary system disease:urethral obstruction",
        "llm_ranking": [
            {
                "entity_name": "FGF1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P05230/entry"
            },
            {
                "entity_name": "FGF2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P09038/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Signaling by FGFR1 in disease",
                "entity_link": "https://reactome.org/PathwayBrowser/#/R-HSA-5655302"
            }
        ]
    },
    {
        "question_number": 18,
        "qid": 997,
        "text": "Which drugs are used to treat lymphoma and have proteinuria as a side effect?",
        "category": "Abnormality of the genitourinary system:Abnormality of the urinary system physiology",
        "llm_ranking": [
            {
                "entity_name": "2-Fluoroadenosine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB04441"
            },
            {
                "entity_name": "Tacrolimus",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00864"
            },
            {
                "entity_name": "Ifosfamide",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01181"
            },
            {
                "entity_name": "Fludarabine",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB01073"
            },
            {
                "entity_name": "Acitretin",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00459"
            },
            {
                "entity_name": "Gemcitabine",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00441"
            },
            {
                "entity_name": "Mitoxantrone",
                "llm_rank": 7,
                "entity_link": "https://go.drugbank.com/drugs/DB01204"
            },
            {
                "entity_name": "Methotrexate",
                "llm_rank": 8,
                "entity_link": "https://go.drugbank.com/drugs/DB00563"
            }
        ],
        "resource": []
    },
    {
        "question_number": 19,
        "qid": 1024,
        "text": "Which proteins are linked to nephrotic syndrome and are involved in the Oxomemazine H1-antihistamine action pathway?",
        "category": "urinary system disease:proteinuria",
        "llm_ranking": [
            {
                "entity_name": "NFKB1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P19838/entry"
            },
            {
                "entity_name": "PLCB1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9NQ66/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Oxomemazine H1-Antihistamine Action",
                "entity_link": "http://smpdb.ca/view/SMP0059738"
            }
        ]
    },
    {
        "question_number": 20,
        "qid": 1085,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to glomerulosclerosis, and interact with MAPK10?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "TP53",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04637/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "MAPK10",
                "entity_link": "https://www.uniprot.org/uniprotkb/P53779/entry"
            }
        ]
    },
    {
        "question_number": 21,
        "qid": 1096,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with the HTT protein?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "GAB2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UQC2/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "TP53",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04637/entry"
            },
            {
                "entity_name": "PIK3R1",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P27986/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "HTT",
                "entity_link": "https://www.uniprot.org/uniprotkb/P42858/entry"
            }
        ]
    },
    {
        "question_number": 22,
        "qid": 1112,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with BMX?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "CBL",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P22681/entry"
            },
            {
                "entity_name": "TP53",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04637/entry"
            },
            {
                "entity_name": "CRKL",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46109/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "BMX",
                "entity_link": "https://www.uniprot.org/uniprotkb/P51813/entry"
            }
        ]
    },
    {
        "question_number": 23,
        "qid": 1127,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with GOLPH3?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "CRK",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "MYC",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01106/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "GOLPH3",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9H4A6/entry"
            }
        ]
    },
    {
        "question_number": 24,
        "qid": 1155,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with PRAG1?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "CRKL",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46109/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "PRAG1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q86YV5/entry"
            }
        ]
    },
    {
        "question_number": 25,
        "qid": 1194,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with IRS4?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "PIK3R1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P27986/entry"
            },
            {
                "entity_name": "MTOR",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P42345/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "CRKL",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46109/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "IRS4",
                "entity_link": "https://www.uniprot.org/uniprotkb/O14654/entry"
            }
        ]
    },
    {
        "question_number": 26,
        "qid": 1200,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with TGFB1I1?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "CRKL",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46109/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "MYC",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01106/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "TGFB1I1",
                "entity_link": "https://www.uniprot.org/uniprotkb/O43294/entry"
            }
        ]
    },
    {
        "question_number": 27,
        "qid": 1204,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with glomerulosclerosis, and known to interact with IRS4?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "MTOR",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P42345/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "IRS4",
                "entity_link": "https://www.uniprot.org/uniprotkb/O14654/entry"
            }
        ]
    },
    {
        "question_number": 28,
        "qid": 1226,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with glomerulosclerosis, and known to interact with GOLPH3?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "CRK",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "MYC",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01106/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "GOLPH3",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9H4A6/entry"
            }
        ]
    },
    {
        "question_number": 29,
        "qid": 1238,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with ovarian disease, and known to interact with BCAR1?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "JAK2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/O60674/entry"
            },
            {
                "entity_name": "PIK3R1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P27986/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            },
            {
                "entity_name": "RPS6KB1",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P23443/entry"
            },
            {
                "entity_name": "CBL",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P22681/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "CRKL",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46109/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "BCAR1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P56945/entry"
            }
        ]
    },
    {
        "question_number": 30,
        "qid": 1242,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to glomerulosclerosis, and interact with FGFR3?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "JAK2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/O60674/entry"
            },
            {
                "entity_name": "MYC",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01106/entry"
            },
            {
                "entity_name": "TP53",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04637/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "FGFR3",
                "entity_link": "https://www.uniprot.org/uniprotkb/P22607/entry"
            }
        ]
    },
    {
        "question_number": 31,
        "qid": 1274,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with LPXN?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "CRK",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "CRKL",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46109/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "LPXN",
                "entity_link": "https://www.uniprot.org/uniprotkb/O60711/entry"
            }
        ]
    },
    {
        "question_number": 32,
        "qid": 1285,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with glomerulosclerosis, and known to interact with the HTT protein?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "TP53",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04637/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "HTT",
                "entity_link": "https://www.uniprot.org/uniprotkb/P42858/entry"
            }
        ]
    },
    {
        "question_number": 33,
        "qid": 1295,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with glomerulosclerosis, and known to interact with PEAK1?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "GRB2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "PEAK1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9H792/entry"
            }
        ]
    },
    {
        "question_number": 34,
        "qid": 1302,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with glomerulosclerosis, and known to interact with TGFB1I1?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "CRK",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "MYC",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01106/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "TGFB1I1",
                "entity_link": "https://www.uniprot.org/uniprotkb/O43294/entry"
            }
        ]
    },
    {
        "question_number": 35,
        "qid": 1307,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with glomerulosclerosis, and known to interact with CNTNAP1?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "GRB2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "CNTNAP1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P78357/entry"
            }
        ]
    },
    {
        "question_number": 36,
        "qid": 1323,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with ovarian disease, and known to interact with CNTNAP1?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "CRK",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "CNTNAP1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P78357/entry"
            }
        ]
    },
    {
        "question_number": 37,
        "qid": 1336,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with ovarian disease, and known to interact with PTPN4?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "PIK3R1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P27986/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "PTPN4",
                "entity_link": "https://www.uniprot.org/uniprotkb/P29074/entry"
            }
        ]
    },
    {
        "question_number": 38,
        "qid": 1356,
        "text": "Which proteins are part of the CIN85 complex (CIN85, CRK, BCAR1, CBL, PIK3R1, GRB2, SOS1), are involved in the Bosutinib inhibition of the BCR-ABL pathway, and are associated with ovarian disease?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "CBL",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P22681/entry"
            },
            {
                "entity_name": "SOS1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q07889/entry"
            },
            {
                "entity_name": "PIK3R1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P27986/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            }
        ]
    },
    {
        "question_number": 39,
        "qid": 1369,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with MAPK10?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "BCL2L1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q07817/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "CRKL",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46109/entry"
            },
            {
                "entity_name": "TP53",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04637/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "MAPK10",
                "entity_link": "https://www.uniprot.org/uniprotkb/P53779/entry"
            }
        ]
    },
    {
        "question_number": 40,
        "qid": 1370,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to glomerulosclerosis, and interact with BMX?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "TP53",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P04637/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "BMX",
                "entity_link": "https://www.uniprot.org/uniprotkb/P51813/entry"
            }
        ]
    },
    {
        "question_number": 41,
        "qid": 1372,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to glomerulosclerosis, and interact with WASL?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "CRK",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "WASL",
                "entity_link": "https://www.uniprot.org/uniprotkb/O00401/entry"
            }
        ]
    },
    {
        "question_number": 42,
        "qid": 1396,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with RAC3?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "GRB2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            },
            {
                "entity_name": "PIK3R1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P27986/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "SOS1",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q07889/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "RAC3",
                "entity_link": "https://www.uniprot.org/uniprotkb/P60763/entry"
            }
        ]
    },
    {
        "question_number": 43,
        "qid": 1405,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with glomerulosclerosis, and known to interact with BCAR1?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "RPS6KB1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P23443/entry"
            },
            {
                "entity_name": "JAK2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O60674/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "BCAR1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P56945/entry"
            }
        ]
    },
    {
        "question_number": 44,
        "qid": 1418,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with SHC1?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "MTOR",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P42345/entry"
            },
            {
                "entity_name": "JAK2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O60674/entry"
            },
            {
                "entity_name": "RPS6KB1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P23443/entry"
            },
            {
                "entity_name": "GAB2",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UQC2/entry"
            },
            {
                "entity_name": "CBL",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P22681/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            },
            {
                "entity_name": "SOS1",
                "llm_rank": 8,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q07889/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "SHC1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P29353/entry"
            }
        ]
    },
    {
        "question_number": 45,
        "qid": 1435,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to glomerulosclerosis, and interact with SHC1?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "MTOR",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P42345/entry"
            },
            {
                "entity_name": "JAK2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O60674/entry"
            },
            {
                "entity_name": "RPS6KB1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P23443/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "SHC1",
                "entity_link": "https://www.uniprot.org/uniprotkb/P29353/entry"
            }
        ]
    },
    {
        "question_number": 46,
        "qid": 1482,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with FGFR3?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "CBL",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P22681/entry"
            },
            {
                "entity_name": "MDM2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q00987/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "FGFR3",
                "entity_link": "https://www.uniprot.org/uniprotkb/P22607/entry"
            }
        ]
    },
    {
        "question_number": 47,
        "qid": 1488,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with SOCS6?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "SKP2",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q13309/entry"
            },
            {
                "entity_name": "JAK2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/O60674/entry"
            },
            {
                "entity_name": "STAT5A",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P42229/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "SOCS6",
                "entity_link": "https://www.uniprot.org/uniprotkb/O14544/entry"
            }
        ]
    },
    {
        "question_number": 48,
        "qid": 1502,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, associated with glomerulosclerosis, and known to interact with PRAG1?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "CRK",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "PRAG1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q86YV5/entry"
            }
        ]
    },
    {
        "question_number": 49,
        "qid": 1517,
        "text": "Which proteins are involved in the Bosutinib inhibition of the BCR-ABL pathway, are linked to ovarian disease, and interact with FRS2?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "PIK3R1",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P27986/entry"
            },
            {
                "entity_name": "GAB2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UQC2/entry"
            },
            {
                "entity_name": "GRB2",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P62993/entry"
            },
            {
                "entity_name": "CRKL",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46109/entry"
            },
            {
                "entity_name": "CRK",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/P46108/entry"
            },
            {
                "entity_name": "CBL",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P22681/entry"
            },
            {
                "entity_name": "SOS1",
                "llm_rank": 7,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q07889/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Bosutinib Inhibition of BCR-ABL",
                "entity_link": "http://smpdb.ca/view/SMP0031698"
            },
            {
                "entity_name": "FRS2",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8WU20/entry"
            }
        ]
    },
    {
        "question_number": 50,
        "qid": 248,
        "text": "Which pathways are associated with EPHB3, a target of Vatalanib?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "EPH-ephrin mediated repulsion of cells",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "EPHB-mediated forward signaling",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Ephrin signaling",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "EPH-Ephrin signaling",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Vatalanib",
                "entity_link": "https://go.drugbank.com/drugs/DB04879"
            },
            {
                "entity_name": "EPHB3",
                "entity_link": "https://www.uniprot.org/uniprotkb/P54753/entry"
            }
        ]
    },
    {
        "question_number": 51,
        "qid": 260,
        "text": "Which proteins are targeted by Fosfomycin and also interact with Trametinib?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "MCEE",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q96PE7/entry"
            },
            {
                "entity_name": "CRP",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P02741/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Trametinib",
                "entity_link": "https://go.drugbank.com/drugs/DB08911"
            },
            {
                "entity_name": "Fosfomycin",
                "entity_link": "https://go.drugbank.com/drugs/DB00828"
            }
        ]
    },
    {
        "question_number": 52,
        "qid": 279,
        "text": "Which proteins are identified as targets of Adefovir dipivoxil and are known to interact with Nabumetone?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "SGCB",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q16585/entry"
            },
            {
                "entity_name": "CYP2C9",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P11712/entry"
            },
            {
                "entity_name": "CYP3A4",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08684/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Nabumetone",
                "entity_link": "https://go.drugbank.com/drugs/DB00461"
            },
            {
                "entity_name": "Adefovir dipivoxil",
                "entity_link": "https://go.drugbank.com/drugs/DB00718"
            }
        ]
    },
    {
        "question_number": 53,
        "qid": 280,
        "text": "Which proteins are targeted by Adefovir dipivoxil and also interact with Nabumetone?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "CYP2C9",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P11712/entry"
            },
            {
                "entity_name": "CYP3A4",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08684/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Nabumetone",
                "entity_link": "https://go.drugbank.com/drugs/DB00461"
            },
            {
                "entity_name": "Adefovir dipivoxil",
                "entity_link": "https://go.drugbank.com/drugs/DB00718"
            }
        ]
    },
    {
        "question_number": 54,
        "qid": 297,
        "text": "Which proteins are targeted by Cabazitaxel and also interact with Trametinib?",
        "category": "Abnormality of the genitourinary system:Abnormal reproductive system morphology",
        "llm_ranking": [
            {
                "entity_name": "TUBA4A",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P68366/entry"
            },
            {
                "entity_name": "TUBB1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9H4B7/entry"
            },
            {
                "entity_name": "AR",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P10275/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Trametinib",
                "entity_link": "https://go.drugbank.com/drugs/DB08911"
            },
            {
                "entity_name": "Cabazitaxel",
                "entity_link": "https://go.drugbank.com/drugs/DB06772"
            }
        ]
    },
    {
        "question_number": 55,
        "qid": 301,
        "text": "Which pathways are associated with PDGFRB, a target of the drug Pazopanib?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "PIP3 activates AKT signaling",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Constitutive Signaling by Aberrant PI3K in Cancer",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Signaling by PDGF",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "RAF/MAP kinase cascade",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Downstream signal transduction",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Pazopanib",
                "entity_link": "https://go.drugbank.com/drugs/DB06589"
            },
            {
                "entity_name": "PDGFRB",
                "entity_link": "https://www.uniprot.org/uniprotkb/P09619/entry"
            }
        ]
    },
    {
        "question_number": 56,
        "qid": 306,
        "text": "Which pathways are associated with CYP2A7, a known target of Fluconazole?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "CYP2E1 reactions",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Xenobiotics",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Vitamin A Deficiency",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Retinol Metabolism",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Fatty acids",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Fluconazole",
                "entity_link": "https://go.drugbank.com/drugs/DB00196"
            },
            {
                "entity_name": "CYP2A7",
                "entity_link": "https://www.uniprot.org/uniprotkb/P20853/entry"
            }
        ]
    },
    {
        "question_number": 57,
        "qid": 311,
        "text": "Which proteins are affected by CYP8B1, which is identified as a target of Fluconazole?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "MAFG",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/O15525/entry"
            },
            {
                "entity_name": "CYP17A1",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P05093/entry"
            },
            {
                "entity_name": "TBXAS1",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/P24557/entry"
            },
            {
                "entity_name": "CYP21A2",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/P08686/entry"
            },
            {
                "entity_name": "CYP2R1",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q6VVX0/entry"
            },
            {
                "entity_name": "INS",
                "llm_rank": 6,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01308/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Fluconazole",
                "entity_link": "https://go.drugbank.com/drugs/DB00196"
            },
            {
                "entity_name": "CYP8B1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q9UNU6/entry"
            }
        ]
    },
    {
        "question_number": 58,
        "qid": 335,
        "text": "Which proteins are metabolized or affected by CYP2A7, which is identified as a target of Fluconazole?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "CYP2D6",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P10635/entry"
            },
            {
                "entity_name": "CYP1A2",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P05177/entry"
            },
            {
                "entity_name": "CYP4V2",
                "llm_rank": 3,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q6ZWL3/entry"
            },
            {
                "entity_name": "ACSF3",
                "llm_rank": 4,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q4G176/entry"
            },
            {
                "entity_name": "R3HDM4",
                "llm_rank": 5,
                "entity_link": "https://www.uniprot.org/uniprotkb/Q96D70/entry"
            }
        ],
        "resource": [
            {
                "entity_name": "Fluconazole",
                "entity_link": "https://go.drugbank.com/drugs/DB00196"
            },
            {
                "entity_name": "CYP2A7",
                "entity_link": "https://www.uniprot.org/uniprotkb/P20853/entry"
            }
        ]
    },
    {
        "question_number": 59,
        "qid": 3,
        "text": "What conditions or symptoms is Sitagliptin prescribed to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Type II diabetes mellitus",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Pancreatitis",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Renal insufficiency",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Reactive hypoglycemia",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Diabetic ketoacidosis",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Type I diabetes mellitus",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Hypoglycemia",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Sitagliptin",
                "entity_link": "https://go.drugbank.com/drugs/DB01261"
            }
        ]
    },
    {
        "question_number": 60,
        "qid": 8,
        "text": "What conditions or symptoms is Goserelin commonly prescribed to treat?",
        "category": "Abnormality of the genitourinary system:Abnormal reproductive system morphology",
        "llm_ranking": [
            {
                "entity_name": "Uterine leiomyoma",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Endometriosis",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Prostate cancer",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Metrorrhagia",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Menorrhagia",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Anemia",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Neoplasm",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Pain",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Goserelin",
                "entity_link": "https://go.drugbank.com/drugs/DB00014"
            }
        ]
    },
    {
        "question_number": 61,
        "qid": 13,
        "text": "What conditions or diseases is Bleomycin commonly used to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the genital system",
        "llm_ranking": [
            {
                "entity_name": "Pleural effusion",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Choriocarcinoma",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Squamous cell carcinoma",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Hodgkin lymphoma",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Lymphoma",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Non-Hodgkin lymphoma",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Neoplasm",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Bleomycin",
                "entity_link": "https://go.drugbank.com/drugs/DB00290"
            }
        ]
    },
    {
        "question_number": 62,
        "qid": 14,
        "text": "Which genes are identified as targets of Glipizide?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "ATP binding cassette subfamily C member 8",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "potassium inwardly rectifying channel subfamily J member 11",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "potassium inwardly rectifying channel subfamily J member 10",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "potassium inwardly rectifying channel subfamily J member 1",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "glucose-6-phosphate dehydrogenase",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "solute carrier family 2 member 4",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Glipizide",
                "entity_link": "https://go.drugbank.com/drugs/DB01067"
            }
        ]
    },
    {
        "question_number": 63,
        "qid": 15,
        "text": "What conditions or phenotypes is Dabrafenib approved to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Cutaneous melanoma",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Renal insufficiency",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Abnormal pulmonary Interstitial morphology",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Pneumonia",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Dabrafenib",
                "entity_link": "https://go.drugbank.com/drugs/DB08912"
            }
        ]
    },
    {
        "question_number": 64,
        "qid": 17,
        "text": "Which genes are identified as targets of Leflunomide?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "dihydroorotate dehydrogenase (quinone)",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "C-X-C motif chemokine ligand 8",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "matrix metallopeptidase 1",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Leflunomide",
                "entity_link": "https://go.drugbank.com/drugs/DB01097"
            }
        ]
    },
    {
        "question_number": 65,
        "qid": 28,
        "text": "Which genes are known to be targets of Glimepiride?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "potassium inwardly rectifying channel subfamily J member 11",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "ATP binding cassette subfamily C member 8",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "potassium inwardly rectifying channel subfamily J member 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "cholecystokinin A receptor",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "insulin receptor substrate 1",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "glucose-6-phosphate dehydrogenase",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "tumor necrosis factor",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Glimepiride",
                "entity_link": "https://go.drugbank.com/drugs/DB00222"
            }
        ]
    },
    {
        "question_number": 66,
        "qid": 33,
        "text": "Which genes are identified as targets of Itraconazole?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "high mobility group box 1",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "NAD(P)H quinone dehydrogenase 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "luteinizing hormone/choriogonadotropin receptor",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "interleukin 2",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "ATP binding cassette subfamily G member 2 (Junior blood group)",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "ATP binding cassette subfamily B member 1",
                "llm_rank": 6,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Itraconazole",
                "entity_link": "https://go.drugbank.com/drugs/DB01167"
            }
        ]
    },
    {
        "question_number": 67,
        "qid": 43,
        "text": "For which diseases is FSHB considered a biomarker?",
        "category": "reproductive system disease:ovarian disease",
        "llm_ranking": [
            {
                "entity_name": "pituitary gland disease",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "ovarian disease",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "FSHB",
                "entity_link": "https://www.uniprot.org/uniprotkb/P01225/entry"
            }
        ]
    },
    {
        "question_number": 68,
        "qid": 45,
        "text": "What conditions or symptoms is citric acid commonly used to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Gout",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Nephrolithiasis",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Nephropathy",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Renal tubular acidosis",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Agitation",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Metabolic acidosis",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Alkalosis",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Acidosis",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Citric acid",
                "entity_link": "https://go.drugbank.com/drugs/DB04272"
            }
        ]
    },
    {
        "question_number": 69,
        "qid": 46,
        "text": "Which diseases use SHBG (sex hormone-binding globulin) as a biomarker?",
        "category": "reproductive system disease:infertility",
        "llm_ranking": [
            {
                "entity_name": "infertility",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "endocrine system disease",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "pituitary gland disease",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "SHBG",
                "entity_link": "https://www.uniprot.org/uniprotkb/P04278/entry"
            }
        ]
    },
    {
        "question_number": 70,
        "qid": 56,
        "text": "What conditions or symptoms is Glipizide prescribed to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Type II diabetes mellitus",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Nephropathy",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Peripheral neuropathy",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Ketosis",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Obesity",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Hyperglycemia",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Diabetes mellitus",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Type I diabetes mellitus",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Glipizide",
                "entity_link": "https://go.drugbank.com/drugs/DB01067"
            }
        ]
    },
    {
        "question_number": 71,
        "qid": 58,
        "text": "For which diseases is SHBG considered a biomarker?",
        "category": "reproductive system disease:infertility",
        "llm_ranking": [
            {
                "entity_name": "infertility",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "endocrine system disease",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "pituitary gland disease",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "SHBG",
                "entity_link": "https://www.uniprot.org/uniprotkb/P04278/entry"
            }
        ]
    },
    {
        "question_number": 72,
        "qid": 65,
        "text": "What conditions or symptoms is Linagliptin prescribed to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Type II diabetes mellitus",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Renal insufficiency",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Pancreatitis",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Diabetic ketoacidosis",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Type I diabetes mellitus",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Linagliptin",
                "entity_link": "https://go.drugbank.com/drugs/DB08882"
            }
        ]
    },
    {
        "question_number": 73,
        "qid": 70,
        "text": "What conditions or symptoms is Aztreonam commonly prescribed to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the lower urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Pyelonephritis",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Recurrent lower respiratory tract infections",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Meningitis",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Sepsis",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Peritonitis",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Pneumonia",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Urinary bladder inflammation",
                "llm_rank": 7,
                "entity_link": null
            },
            {
                "entity_name": "Bronchitis",
                "llm_rank": 8,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Aztreonam",
                "entity_link": "https://go.drugbank.com/drugs/DB00355"
            }
        ]
    },
    {
        "question_number": 74,
        "qid": 87,
        "text": "What conditions or phenotypes is Alendronic acid commonly prescribed to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Osteopenia",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Generalized osteoporosis",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Vertebral compression fractures",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Neoplasm",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Abnormality of the gastrointestinal tract",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Renal insufficiency",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Peptic ulcer",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Alendronic acid",
                "entity_link": "https://go.drugbank.com/drugs/DB00630"
            }
        ]
    },
    {
        "question_number": 75,
        "qid": 97,
        "text": "What conditions or symptoms is Sorbitol commonly used to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Fructose intolerance",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Cerebral edema",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Ocular hypertension",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Asthma",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Acute kidney injury",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Sorbitol",
                "entity_link": "https://go.drugbank.com/drugs/DB01638"
            }
        ]
    },
    {
        "question_number": 76,
        "qid": 98,
        "text": "What conditions or symptoms is Tetracycline commonly prescribed to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Recurrent lower respiratory tract infections",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Renal insufficiency",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Tetracycline",
                "entity_link": "https://go.drugbank.com/drugs/DB00759"
            }
        ]
    },
    {
        "question_number": 77,
        "qid": 106,
        "text": "What conditions or diseases is Alendronic acid commonly prescribed to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Vertebral compression fractures",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Neoplasm",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Generalized osteoporosis",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Renal insufficiency",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Osteopenia",
                "llm_rank": 5,
                "entity_link": null
            },
            {
                "entity_name": "Abnormality of the gastrointestinal tract",
                "llm_rank": 6,
                "entity_link": null
            },
            {
                "entity_name": "Peptic ulcer",
                "llm_rank": 7,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Alendronic acid",
                "entity_link": "https://go.drugbank.com/drugs/DB00630"
            }
        ]
    },
    {
        "question_number": 78,
        "qid": 107,
        "text": "What conditions or symptoms is Solifenacin prescribed to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the lower urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Pollakisuria",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Urinary urgency",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Solifenacin",
                "entity_link": "https://go.drugbank.com/drugs/DB01591"
            }
        ]
    },
    {
        "question_number": 79,
        "qid": 130,
        "text": "What conditions or symptoms is Nizatidine prescribed to treat?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Renal insufficiency",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "Duodenal ulcer",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "Gastric ulcer",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "Gastroesophageal reflux",
                "llm_rank": 4,
                "entity_link": null
            },
            {
                "entity_name": "Esophagitis",
                "llm_rank": 5,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Nizatidine",
                "entity_link": "https://go.drugbank.com/drugs/DB00585"
            }
        ]
    },
    {
        "question_number": 80,
        "qid": 142,
        "text": "Which diseases is PLA2G1B considered a biomarker for?",
        "category": "urinary system disease:kidney disease",
        "llm_ranking": [
            {
                "entity_name": "immune system disease",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "kidney disease",
                "llm_rank": 2,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "PLA2G1B",
                "entity_link": "https://www.uniprot.org/uniprotkb/P04054/entry"
            }
        ]
    },
    {
        "question_number": 81,
        "qid": 156,
        "text": "Which drugs are used to treat heavy menstrual bleeding (menorrhagia)?",
        "category": "Abnormality of the genitourinary system:Abnormality of reproductive system physiology",
        "llm_ranking": [
            {
                "entity_name": "Tranexamic acid",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00302"
            },
            {
                "entity_name": "Danazol",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01406"
            },
            {
                "entity_name": "Desmopressin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00035"
            },
            {
                "entity_name": "Mefenamic acid",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00784"
            },
            {
                "entity_name": "Levonorgestrel",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00367"
            },
            {
                "entity_name": "Goserelin",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00014"
            }
        ],
        "resource": []
    },
    {
        "question_number": 82,
        "qid": 169,
        "text": "Which drugs specifically target natriuretic peptide receptor 2 (NPR2)?",
        "category": "Abnormality of the genitourinary system:Abnormality of reproductive system physiology",
        "llm_ranking": [
            {
                "entity_name": "Nesiritide",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB04899"
            },
            {
                "entity_name": "Erythrityl tetranitrate",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01613"
            },
            {
                "entity_name": "Ketoprofen",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01009"
            }
        ],
        "resource": []
    },
    {
        "question_number": 83,
        "qid": 187,
        "text": "Which drugs are used to treat kidney stones?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Topiramate",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00273"
            },
            {
                "entity_name": "Citric acid",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB04272"
            },
            {
                "entity_name": "Norfloxacin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB01059"
            }
        ],
        "resource": []
    },
    {
        "question_number": 84,
        "qid": 189,
        "text": "Which drugs are used to treat cryptorchidism (undescended testicles)?",
        "category": "Abnormality of the genitourinary system:Abnormal reproductive system morphology",
        "llm_ranking": [
            {
                "entity_name": "Fluoxymesterone",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01185"
            },
            {
                "entity_name": "Epitestosterone",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB07768"
            },
            {
                "entity_name": "Methyltestosterone",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB06710"
            },
            {
                "entity_name": "Testosterone",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00624"
            }
        ],
        "resource": []
    },
    {
        "question_number": 85,
        "qid": 208,
        "text": "Which drugs are commonly prescribed for the treatment of chronic kidney disease?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Cinacalcet",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB01012"
            },
            {
                "entity_name": "Ramipril",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB00178"
            },
            {
                "entity_name": "Sevelamer",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB00658"
            },
            {
                "entity_name": "Paricalcitol",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB00910"
            },
            {
                "entity_name": "Ezetimibe",
                "llm_rank": 5,
                "entity_link": "https://go.drugbank.com/drugs/DB00973"
            },
            {
                "entity_name": "Hydrochlorothiazide",
                "llm_rank": 6,
                "entity_link": "https://go.drugbank.com/drugs/DB00999"
            }
        ],
        "resource": []
    },
    {
        "question_number": 86,
        "qid": 214,
        "text": "Which drugs target deoxycytidine kinase (DCK)?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "Cladribine",
                "llm_rank": 1,
                "entity_link": "https://go.drugbank.com/drugs/DB00242"
            },
            {
                "entity_name": "Fludarabine",
                "llm_rank": 2,
                "entity_link": "https://go.drugbank.com/drugs/DB01073"
            },
            {
                "entity_name": "Camptothecin",
                "llm_rank": 3,
                "entity_link": "https://go.drugbank.com/drugs/DB04690"
            },
            {
                "entity_name": "2'-Deoxycytidine",
                "llm_rank": 4,
                "entity_link": "https://go.drugbank.com/drugs/DB02594"
            }
        ],
        "resource": []
    },
    {
        "question_number": 87,
        "qid": 219,
        "text": "Which proteins are considered biomarkers for glomerulonephritis?",
        "category": "urinary system disease:nephritis",
        "llm_ranking": [
            {
                "entity_name": "C4A",
                "llm_rank": 1,
                "entity_link": "https://www.uniprot.org/uniprotkb/P0C0L4/entry"
            },
            {
                "entity_name": "C3",
                "llm_rank": 2,
                "entity_link": "https://www.uniprot.org/uniprotkb/P01024/entry"
            }
        ],
        "resource": []
    },
    {
        "question_number": 88,
        "qid": 390,
        "text": "Which genes are identified as targets of citric acid, which affects ABCF1 and is known to interact with PCSK4?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "cholinergic receptor muscarinic 1",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "polycystin 2 like 1, transient receptor potential cation channel",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "cholinergic receptor muscarinic 4",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "sigma non-opioid intracellular receptor 1",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "PCSK4",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q6UW60/entry"
            },
            {
                "entity_name": "ABCF1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8NE71/entry"
            },
            {
                "entity_name": "Citric acid",
                "entity_link": "https://go.drugbank.com/drugs/DB04272"
            }
        ]
    },
    {
        "question_number": 89,
        "qid": 408,
        "text": "Which genes are identified as targets of Codeine, which affects the C5 protein, a biomarker for kidney disease?",
        "category": "urinary system disease:kidney disease",
        "llm_ranking": [
            {
                "entity_name": "cytochrome P450 family 2 subfamily D member 6",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor delta 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor mu 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "opioid receptor kappa 1",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "C5",
                "entity_link": "https://www.uniprot.org/uniprotkb/P01031/entry"
            },
            {
                "entity_name": "Codeine",
                "entity_link": "https://go.drugbank.com/drugs/DB00318"
            }
        ]
    },
    {
        "question_number": 90,
        "qid": 410,
        "text": "Which genes are identified as targets of Acyclovir, which affects HAAO and is involved in the Disulfiram Action Pathway?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "ABL proto-oncogene 1, non-receptor tyrosine kinase",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "interleukin 10",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "solute carrier family 15 member 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "DNA nucleotidylexotransferase",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "Disulfiram Action Pathway",
                "entity_link": "http://smpdb.ca/view/SMP0000429"
            },
            {
                "entity_name": "HAAO",
                "entity_link": "https://www.uniprot.org/uniprotkb/P46952/entry"
            },
            {
                "entity_name": "Acyclovir",
                "entity_link": "https://go.drugbank.com/drugs/DB00787"
            }
        ]
    },
    {
        "question_number": 91,
        "qid": 417,
        "text": "Which genes are identified as targets of citric acid, which affects AMZ1 and is known to interact with CYFIP1?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "cholinergic receptor muscarinic 1",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "polycystin 2 like 1, transient receptor potential cation channel",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "cholinergic receptor muscarinic 4",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "sigma non-opioid intracellular receptor 1",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "CYFIP1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q7L576/entry"
            },
            {
                "entity_name": "AMZ1",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q400G9/entry"
            },
            {
                "entity_name": "Citric acid",
                "entity_link": "https://go.drugbank.com/drugs/DB04272"
            }
        ]
    },
    {
        "question_number": 92,
        "qid": 438,
        "text": "Which genes are identified as targets of citric acid, which affects ACOT12 and is known to interact with ACOT7?",
        "category": "Abnormality of the genitourinary system:Abnormality of the upper urinary tract",
        "llm_ranking": [
            {
                "entity_name": "cholinergic receptor muscarinic 1",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "polycystin 2 like 1, transient receptor potential cation channel",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "sigma non-opioid intracellular receptor 1",
                "llm_rank": 3,
                "entity_link": null
            },
            {
                "entity_name": "cholinergic receptor muscarinic 4",
                "llm_rank": 4,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "ACOT7",
                "entity_link": "https://www.uniprot.org/uniprotkb/O00154-4/entry"
            },
            {
                "entity_name": "ACOT12",
                "entity_link": "https://www.uniprot.org/uniprotkb/Q8WYK0/entry"
            },
            {
                "entity_name": "Citric acid",
                "entity_link": "https://go.drugbank.com/drugs/DB04272"
            }
        ]
    },
    {
        "question_number": 93,
        "qid": 440,
        "text": "Which genes are identified as targets of Afimoxifene, a drug that acts on PGRMC1, a component of the PGRMC1-SCAP complex?",
        "category": "Abnormality of the genitourinary system:Abnormality of reproductive system physiology",
        "llm_ranking": [
            {
                "entity_name": "estrogen receptor 2",
                "llm_rank": 1,
                "entity_link": null
            },
            {
                "entity_name": "estrogen receptor 1",
                "llm_rank": 2,
                "entity_link": null
            },
            {
                "entity_name": "fibroblast growth factor receptor 1",
                "llm_rank": 3,
                "entity_link": null
            }
        ],
        "resource": [
            {
                "entity_name": "PGRMC1",
                "entity_link": "https://www.uniprot.org/uniprotkb/O00264/entry"
            },
            {
                "entity_name": "Afimoxifene",
                "entity_link": "https://go.drugbank.com/drugs/DB04468"
            }
        ]
    }
]